Trxade adds independent director to company board

On Wednesday, Trxade Group — a web-based market platform which enables independent pharmacy customers to purchase and source pharmaceuticals from a wide range of manufacturers and drug distributors — announced the addition of Michael Peterson to the company's board of directors.

The Trxade board now consists of four directors, two of whom — including Mr. Peterson — are independent. Mr. Peterson has operated as CEO of Pedevco since May 2016, previously having served as the company's CFO since July 2012. Pedevco is a public company primarily engaged in the acquisition and development of oil and natural gas shale plays.

"Trxade Group is a leader in pharmaceutical trading platforms with innovative, market-leading technologies and the company is well-positioned to take advantage of multiple opportunities," said Donald Fell, chairman of the nomination committee. "Given his experience and deep knowledge in public companies as a CFO, I believe that Mr. Peterson will be an extremely valuable resource to the company going forward."

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars

>